GABRIELA POBAR: Open Payments
NPI 1689223125 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 36 payments from 13 companies in 2025. Trend: 2023 $1,576 · 2024 $1,117 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $156 |
| Merck Sharp & Dohme LLC | 7 | $148 |
| AstraZeneca Pharmaceuticals LP | 9 | $146 |
| Caris MPI, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $48 |
| Eisai Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Genmab U.S., Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $28 |
| pharmaand GmbH | 1 | $23 |
Products named: LYNPARZA, BOTOX, ENHERTU, KEYTRUDA, MI CANCER SEEK, Veozah, Lenvima, ELAHERE.
Industry payments across NM — which companies pay providers there.
